Keyword: GlaxoSmithKline, North Carolina

GLAXOSMITHKLINE
Company Name GlaxoSmithKline Inc. 
Address  Morrisville, NC 27560 

Click Here
for Directions

Phone Numbers (919) 483-2565 
StatusReserved Name
 
GLAXOSMITHKLINE
Company Name GlaxoSmithKline Inc. 
Address  Morrisville, NC 27560 

Click Here
for Directions

Phone Numbers (919) 483-2565 
StatusReserved Name
 
 Top  
Stock Info (Source: MSN Money)
NameGlaxoSmithKline plc (ADR) 
Address980 Great West Road Brentford Middlesex ENG TW8 9GS  
Phone888-8255249 
Fax442080477807 
WebSitehttp://www.gsk.com 
Inductry TypeDrug Manufacturers - Major 
Employees99,503 
ExchangeNYSE 
Annual Sales45.6 Bil 
Income10.5 Bil 
Quote52.52   More Quotes
DescriptionGlaxoSmithKline plc (GSK) is a global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. GSK operates in two industry segments: Pharmaceuticals (prescription pharmaceuticals and vaccines), and Consumer Healthcare (over-the-counter medicines, oral care and nutritional healthcare). The major markets for the Company's products are the United States, France, Japan, the United Kingdom, Italy, Germany and Spain. During the year ended December 31, 2005, 18 compounds entered clinical trials. GSK has a portfolio of products, ranging from tablets and toothpaste to inhalers and complex capsules, in over 28,000 different pack sizes and presentations. In July 2006, Ranbaxy Laboratories Limited acquired Mundogen generic business of GSK. On May 5, 2006, the Company acquired PLIVA - Istrazivacki Institut d.o.o. (PLIVA - Research Institute Ltd.), Pliva DD's research and development arm. 
 Top  
Stock Info (Source: MSN Money)
NameGLAXOSMITHKLINE PLC ORD 
ExchangeOther OTC Issues 
Annual SalesNA 
IncomeNA 
Quote25.85   More Quotes
DescriptionCompany description not available. 
 Top  
 
Business Registration (Source: North Carolina Secretary of State)
Legal Name of Business GlaxoSmithKline Inc.  
Business ID  
Status Reserved Name  
Date Formed  
Citizenship Domestic  
State of Incorporation NC  
Duration Perpetual  
Registered Agent Karen Rozar for Corporation Service Company  
Registered Office Address 2711 Centerville Rd., Ste. 400
Wilmington DE 19808
Registered Office Mailing Address  
Business Filing Information (Source: North Carolina Secretary of State)
Filing Date Document ID Document
8/11/2000   202249056   RESR - Application to Reserve a Corporate Name  
12/11/2000   203439118   RESR - Application to Reserve a Corporate Name  
 
Business Registration (Source: North Carolina Secretary of State)
Legal Name of Business GlaxoSmithKline Inc.  
Business ID  
Status Reserved Name  
Date Formed  
Citizenship Domestic  
State of Incorporation NC  
Duration Perpetual  
Registered Agent Karen Rozar for Corporation Service Company  
Registered Office Address 2711 Centerville Rd., Ste. 400
Wilmington DE 19808
Registered Office Mailing Address  
Business Filing Information (Source: North Carolina Secretary of State)
Filing Date Document ID Document
8/11/2000   202249056   RESR - Application to Reserve a Corporate Name  
12/11/2000   203439118   RESR - Application to Reserve a Corporate Name  
 Top  
GLAXOSMITHKLINE
Business Name Glaxosmithkline  
Address Morrisville, NC 27560     View Map
Phone (919) 483-2565  
Specialties Information Line  
Relevance Score 100%  
Business Name Glaxosmithkline  
Address 5 Morse, Durham, NC 27713     View Map
Phone (919) 483-2100  
Brands Creative  
Relevance Score 100%  
 Top  
glaxosmithkline
NameGlaxoSmithKline  
Address5-T Moore Dr., P.O. Box 13398 Research Triangle Park, NC 27709 
Phone919-483-2100, 800-825-5249 (toll free) 
Fax919-549-7459 
# of Employees1000+ 
Line of businessNews & Press Releases Antibiotic, Antidepressant, Gastrointestinal, Dermatological, Respiratory, Cancer & Cardiovascular Pharmaceuticals  
Relevance Score100.00% 
 Top  
GLAXOSMITHKLINE PLC ADR
The search was successfully completed, however no results were found at the DataMonitor site
GLAXOSMITHKLINE PLC ORD
The search was successfully completed, however no results were found at the DataMonitor site
GLAXOSMITHKLINE
The search was successfully completed, however no results were found at the DataMonitor site
 Top  
GLAXOSMITHKLINE PLC ADR
The search was successfully completed, however no results were found at the Hoovers site
GLAXOSMITHKLINE PLC ORD
The search was successfully completed, however no results were found at the Hoovers site
GLAXOSMITHKLINE
The search was successfully completed, however no results were found at the Hoovers site
 Top  
GLAXOSMITHKLINE PLC ADR
The search was successfully completed, however no results were found at the Better Business Bureau
GLAXOSMITHKLINE PLC ORD
Company Name   GlaxoSmithKline PLC  
Address   5 Moore Dr Durham, NC 27709  
Phone   919-483-2100  
Website   www.gsk.com  
Relevance Score   82.61%  
Company Name   GlaxoSmithKline PLC  
Address   PO Box 13398 Durham, NC 27709  
Phone   919-483-2100  
Website   www.gsk.com  
Relevance Score   82.61%  
Company Name   GlaxoSmithKline PLC  
Address   1011 N Arendell Ave Zebulon, NC 27597  
Phone   919-483-2100  
Website   www.gsk.com  
Relevance Score   82.61%  
GLAXOSMITHKLINE
The search was successfully completed, however no results were found at the Better Business Bureau
 Top  
Uniform Commercial Code Filings (Source: North Carolina Secretary of State)
Debtor Name GLAXOSMITHKLINE  
Debtor Address 1011 N ARENDELL AVE, ZEBULON,NC 27597  
Secured Party Name HOBART CORPORATION WORLD HEADQUARTERS  
Secured Party Address 701 S RIDGE AVE, TROY,OH 453740001  
Filing Date3/23/2001  
Lapse Date3/23/2006  
File Number 20010029012  
DocumentsInitial  
No. of pages1  
Debtor Name GLAXOSMITHKLINE  
Debtor Address 1011 N ARENDELL AVE, ZEBULON,NC 27597  
Secured Party Name HOBART CORPORATION WORLD HEADQUARTERS  
Secured Party Address 701 S RIDGE AVE, TROY,OH 453740001  
Filing Date6/25/2001  
Lapse Date  
File Number 20010059903  
DocumentsTermination Secured Party  
No. of pages1  
Debtor Name GLAXOSMITHKLINE  
Debtor Address P O BOX 13358, RESEARCH TRIANGLE PARK,NC 27709  
Secured Party Name IOS Capital, LLC  
Secured Party Address 1738 Bass Road, Macon,GA 31210  
Filing Date6/24/2003  
Lapse Date6/24/2008  
File Number 20030063336H  
DocumentsInitial  
No. of pages2  
 Top  
GLAXOSMITHKLINE PLC ADR
The search was successfully completed, however no US Patents were found
GLAXOSMITHKLINE PLC ORD
The search was successfully completed, however no US Patents were found
 Top  
"GLAXOSMITHKLINE PLC ORD" AND "NORTHCAROLINA"
The search was successfully completed, however no US Trademarks were found
"GLAXOSMITHKLINE PLC ADR" AND "NORTHCAROLINA"
The search was successfully completed, however no US Trademarks were found
 Top  
GLAXOSMITHKLINE PLC ORD
The search was successfully completed, however no Canadian Trademarks were found
The search found the following Canadian Trademarks for this business name. However the search could not assign a high match score. Please verify the results.
GLAXOSMITHKLINE
FLUARIX, Searched, 1307143  
NUMIVIRIX, Searched, 1303752  
NUMOFIRIX, Searched, 1303749  
NUMIFIRIX, Searched, 1303745  
FLULAVAL, Allowed, 1291908  
BLANCHEUR ULTIME, Searched, 1291250  
BLANCHEUR & BRILLIANCE, Searched, 1291248  
ULTIMATE WHITE, Searched, 1291246  
STREPIRIX, Searched, 1094815  
FRESH CLEANSE & DROPS DESIGN, Searched, 1308283  
No one will believe you have a cold, Searched, 1306762  
Personne ne croira que vous avez le rhume, Searched, 1306758  
POLIDENT FRESH CLEANSE, Searched, 1292872  
FRESH CLEANSE, Searched, 1292871  
FLUINCEPT, Searched, 1291909  
UNE TRADITION DE LEADERSHIP ET D'INNOVATION, Searched, 1291447  
A TRADITION OF LEADERSHIP AND INNOVATION, Searched, 1291444  
LEADERSHIP ET INNOVATION, Searched, 1291443  
LEADERSHIP AND INNOVATION, Searched, 1291442  
ILEX & DESIGN, Searched, 1265234  
CONTAC ACTION FRAICHEUR, Searched, 1249171  
CONTAC COOL ACTION, Searched, 1248259  
POLIDENT EXPRESS, Allowed, 1199324  
CLAMYDRIX, Searched, 1112318  
TEGIRIX, Allowed, 0847768  
POLIDENT, Registered, 0169161, UCA007056  
WITH COOLING ACTION, Formalized, 1324170  
NETTOYANT FRAICHEUR, Searched, 1296899  
NETTEMENT FRAIS, Searched, 1296635  
INFLUCEPTOR, Advertised, 1291901  
ULTRA FRESH, Registered, 1278845, TMA677229  
FRESQ, Searched, 1070311  
DEVURE, Searched, 1070310  
EOLARIX, Allowed, 0796288  
WHITETRAYS, Searched, 1305259  
FRAICHEURARCTIQUE, Opposed, 1259573  
A ACTION FRAÎCHEUR, Formalized, 1322717  
A ACTION FRAÎCHEUR, Formalized, 1322716  
SPECTRO ENFANTS, Searched, 1315335  
SPECTRO KIDS, Searched, 1315333  
NUMOCORIX, Searched, 1303750  
SPECTRO DES PETITS, Searched, 1299757  
MAGEOMA, Searched, 1071105  
PAVANIS, Searched, 1016617  
PALLENA, Searched, 1016616  
ULTRAFRAÎCHEUR, Formalized, 1320843  
SPECTRO KIDS ENFANTS, Searched, 1315331  
FRESH CLEANSE NETTEMENT FRAIS & DESIGN, Searched, 1312506  
SPECTRO KIDS, Searched, 1299474  
SPECTRO KIDS ENFANTS ECZEMACARE, Formalized, 1320357  
SPECTRO KIDS ECZEMACARE, Formalized, 1320356  
SPECTRO ECZEMACARE, Formalized, 1320355  
SPECTRO ENFANTS ECZEMACARE, Formalized, 1320354  
ADVANCED CARE, Searched, 1290076  
POLI-GRIP ADVANCED CARE, Advertised, 1284079  
THERHEPA, Searched, 1093822  
POLIGRIP, Formalized, 1319952  
POLIGRIP, Formalized, 1318328  
PRIORIX-VAR, Allowed, 1077539  
EXILOMA, Searched, 1030923  
OASIS, Searched, 1299845  
FLUACTAL, Advertised, 1291907  
ADABOOST, Searched, 1289206  
ADBOOST, Searched, 1289205  
INFABOOST, Searched, 1289204  
SOOTHING CINNAMON, Allowed, 1276136  
WITH COOLING ACTION, Registered, 1259436, TMA672947  
ULTRA POLIGRIP BOUT ANTIFUITE, Registered, 1191401, TMA620667  
ULTRA POLIGRIP OOZE-CONTROL TIP, Registered, 1191398, TMA620211  
EPVACTIN, Default - Searched, 1010046  
FENDRIX & DESIGN, Allowed, 1189740  
MOSQUIRIX, Allowed, 1007794  
N'OUBLIEZ PAS VOTRE LANGUE, Allowed, 1270414  
DON'T FORGET YOUR TONGUE, Allowed, 1270413  
CERVARIX, Searched, 1143479  
AIDSRIX, Searched, 1108559  
SIDARIX, Searched, 1108558  
EPZECTA, Allowed, 1007423  
GLOBORIX, Allowed, 0893209  
HIBMENRIX, Formalized, 1314873  
VERPREL, Allowed, 1090986  
SPECTRO GLUVS, Allowed, 1069531  
VISARIX, Allowed, 0893208  
MONDRIX, Allowed, 0893207  
EASIRIX, Allowed, 0892624  
ROVENTRIX, Allowed, 0892005  
VAMRIX, Allowed, 0857752  
VARIMIR, Allowed, 0857751  
BONRIX, Allowed, 0857254  
FENDRIX, Allowed, 0857253  
PROMRIX, Allowed, 0857252  
CEVARIX, Searched, 1143480  
FLUZACTAL, Searched, 1291906  
RIXARIX, Searched, 0876916  
INFLUSPLIT, Abandoned - Section 40(3), 0753722  
FLUARIX, Abandoned - Section 40(3), 0740363  
PACIRIX, Opposed, 1259849  
NECYRIX, Allowed, 1259848  
COMENRIX, Allowed, 1259847  
ANCYRIX, Allowed, 1259845  
GLAXOSMITHKLINE PLC ADR
The search was successfully completed, however no Canadian Trademarks were found
 Top  
GLAXOSMITHKLINE PLC ORD
The search was successfully completed, however no Canadian Patents were found
GLAXOSMITHKLINE
The search found the following Canadian Patents for this business name. However the search could not assign a high match score. Please verify the results.
NumberDescription
2510457   HPV-16 AND -18 L1 VLP VACCINE  
2496045   METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN  
2495086   MUTANT PROTEIN AND REFOLDING METHOD  
2494002   ANTIGENIC COMPOSITIONS  
2493977   VACCINE COMPOSITION COMPRISING LIPOOLIGOSACCHARIDE WITH REDUCED PHASE VARIABILITY  
2427842   SPLIT ENVELOPED VIRUS PREPARATION FOR INTRANASAL DELIVERY  
2427475   PURIFICATION OF HBV ANTIGENS FOR USE IN VACCINES  
2393303   HETEROCYCLIC DERIVATIVES  
2550927   VACCINE  
2548512   VACCINE COMPRISING IL-12 OR IL-23 FOR TREATMENT OF AUTOIMMUNE DISEASES  
2541695   VACCINE COMPOSITIONS COMPRISING AN INTERLEUKIN 18 AND SAPONIN ADJUVANT SYSTEM  
2541693   IMMUNOGENIC COMPOSITIONS  
2539715   PERTUSSIS ANTIGENS AND USE THEREOF IN VACCINATION  
2536734   VACCINE  
2534048   NOVEL DEVICE  
2531046   PROCESS AND APPARATUS FOR PRODUCING A VIAL IN A STERILE ENVIRONMENT  
2526416   POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZA B SACCHARIDE VACCINES  
2523405   DEVICE FOR INTRODUCING A LIQUID INTO A PHARMACEUTICAL CONTAINER  
2523015   GUANIDINO-SUBSTITUTED QUINAZOLINONE COMPOUNDS AS MC4-R AGONISTS  
2518669   PURIFICATION PROCESS FOR BACTERIAL CYTOLYSIN  
2517327   ANIMAL-FREE CELL CULTURE METHOD  
2516766   APPARATUS AND PROCESS FOR FILLING A MEDICAMENT INTO A CONTAINER  
2513836   HYPOALLERGENIC DER P1 AND DER P3 PROTEINS FROM DERMATOGRAPHOIDES PTERONYSSINUS  
2505100   TOOTHBRUSH  
2503946   DRYING PROCESS  
2503871   IMMUNOGENIC COMPOSITION  
2503364   METHOD AND KIT FOR DETECTING ANTIGENS  
2502268   METHODS FOR VACCINATING AGAINST MALARIA  
2498942   NOVEL DEVICE  
2495214   CLOSURE SYSTEM FOR A VIAL, VIAL, METHOD OF CLOSING AND FILLING A VIAL AND STAND FOR A VIAL  
2493124   VACCINE COMPOSITIONS COMPRISING L2 AND/OR L3 IMMUNOTYPE LIPOOLIGOSACCHARIDES FROM LGTB- NEISSERIA MINIGITIDIS  
2493092   NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS  
2491896   MONITORING OF CELLS  
2489030   VACCINE COMPOSITION COMPRISING TRANSFERRIN BINDING PROTEIN AND HSF FROM GRAM NEGATIVE BACTERIA  
2488782   VACCINE COMPRISING MIXTURES OF MULTIVALENT MENINGOCOCCAL OUTER MEMBRANE VESCILES  
2487907   IMMUNOGENIC COMPOSITIONS COMPRISING A XENOGENIC PROSTATE PROTEIN P501S  
2487831   IMMUNOGENIC COMPOSITIONS  
2484645   EBV VACCINE USING GP350 ANTIGEN  
2480786   RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE  
2479307   VIRUS LIKE PARTICLE FROM PAPILLOMAVIRUS AND THEIR USE IN VACCINE  
2479304   VIRUS-LIKE PARTICLES OF HUMAN PAPILLOMAVIRUS  
2472123   PROTEINS OF NON TYPABLE HAEMOPHILUS INFLUENZAE  
2470645   STREPTOCOCCUS PNEUMONIAE VACCINE  
2462946   RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE PROTEIN-1/42 VACCINE  
2462205   TOOTHBRUSH  
2461924   VACCINE  
2458237   VACCINE THERAPIES AND PROPHYLACTIC TREATMENTS OF ATHEROSCLEROTIC DISEASES  
2457163   DERP1 AND PRODERP1 ALLERGEN DERIVATIVES  
2457111   VACCINE FOR TREATING ALLERGY  
2456568   METHOD FOR IDENTIFICATION OF TYPE SPECIFIC POLYNUCLEOTIDE SEQUENCES  
 Top  
GLAXOSMITHKLINE PLC (ADR)
GSK buys British biotech for $454M - 12/08/06
GlaxoSmithKline agreed Friday to buy Domantis Ltd., a privately held biotechnology company, for $454 million in cash. ... bizjournals.com 
Market Report -- In Play (GSK) - 12/08/06
GlaxoSmithKline confirms agreement to acquire Domantis Co confirms that it has entered into an agreement to acquire Domantis Ltd, a leader in developing the next generation of antibody therapies, for... ... Briefing.com 
GlaxoSmithKline to Acquire Domantis for 230 Million Pounds... - 12/08/06
GSK Will Further Expand Its Biopharmaceuticals Portfolio With Acquisition of Pioneering Antibody Technology LONDON, Dec. 8 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc... ... PRNewswire 
GlaxoSmithKline to buy English biotech firm - 12/08/06
GlaxoSmithKline agreed Friday to buy Domantis Ltd., a privately held biotechnology company, for $454 million in cash. ... bizjournals.com 
Domantis to be acquired by GlaxoSmithKline - 12/08/06
Drug developer Domantis is being acquired by GlaxoSmithKline plc in a $454 million deal expected to end the company's efforts to expand into Massachusetts. ... bizjournals.com 
GlaxoSmithKline to buy English biotech firm - 12/08/06
GlaxoSmithKline agreed Friday to buy Domantis Ltd., a privately held biotechnology company, for $454 million in cash. ... bizjournals.com 
Glaxo Buys Domantis for $454 Million - 12/08/06
LONDON (AP) - GlaxoSmithKline PLC said Friday it had acquired the privately held biotechnology company Domantis Ltd. for 230 million pounds ($454 million) in cash. ... AP 
GlaxoSmithKline Announces New Patient Assistance Programs ... - 12/07/06
PHILADELPHIA, Dec. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) has expanded its patient assistance programs, offering its retail prescription medicines for free to eligible low-income... ... PRNewswire 
Dry Mouth Sufferers Find Their Oasis(R) -- Video Available - 12/05/06
Unique Mouthwash and Mouth Spray Provide Lasting Moisturization PITTSBURGH, Dec. 5 /PRNewswire-FirstCall/ -- On an average day, the human mouth will normally produce two to four pints of... ... PRNewswire 
Success for Dynavax - 12/04/06
Solid results from the first of three phase III trials cause Dynavax's shares to rise. ... Motley Fool 
Dynavax Shares Rise on Study Results - 12/04/06
NEW YORK (AP) - Shares of drug developer Dynavax Technologies Corp. jumped Monday after the company said new data from a study of its hepatitis B vaccine candidate showed it is effective despite a time lag between doses. ... AP 
Reap profits from the war on cancer - 12/01/06
Big changes, like the booming market in new, effective anti-cancer treatments, are reshaping the sector. Here are the drug makers in the best position to reap rewards in 2007. ... MSN Money 
Brit Pound Hits 14-Year High Vs. Dollar - 11/30/06
LONDON (AP) - The pound hit a 14-year high against the dollar Thursday, providing a pre-Christmas boon for British tourists in the United States but raising fears for exporters as analysts predict a further slump in the U.S. currency. ... AP 
GLAXOSMITHKLINE PLC ORD
Dry Mouth Sufferers Find Their Oasis(R) -- Video Available - 12/05/06
Unique Mouthwash and Mouth Spray Provide Lasting Moisturization PITTSBURGH, Dec. 5 /PRNewswire-FirstCall/ -- On an average day, the human mouth will normally produce two to four pints of... ... PRNewswire 
"GLAXOSMITHKLINE PLC ORD", NORTHCAROLINA
GlaxoSmithKline - Do more, feel better, live longer
This site serves as the homepage of GSK's corporate web site.
http://www.gsk.com/  
SH-SAN-50111 Life/Tech_v6
120000 GlaxoSmithKline plc ORD . 3319877. 84000 Johnson & Johnson. 5058480. 91250 Novartis AG ADR. 5062550. 183000 Pfizer Inc. 4329780 ...
http://www.americancentury.com/funds/reports_pdf/techlife.pdf  
Semiannual Report
187880 GlaxoSmithKline plc ORD . 5197820. 52360 Johnson & Johnson. 3153119 ... 138740 GlaxoSmithKline plc ORD . 3838331. 27570 Johnson & Johnson. 1660265 ...
http://www.americancentury.com/funds/reports_pdf/Strategic_investor_report.pdf  
a 15.02000 15.30000 14.57000 14.9600 1569600 agi
... North Carolina BKNG,23.91000,23.91000,23.91000,23.9100,0,Banknorth Group ... GLAXF,18.85000,18.85000,18.85000,18.8500,0, Glaxosmithkline Plc Ord GLB ...
http://members.aol.com/_ht_a/CwooL97945/Sample/quotfile.txt  
"GLAXOSMITHKLINE PLC ADR", NORTHCAROLINA
News for GlaxoSmithKline plc (ADR ) - Google Finance
News for GlaxoSmithKline plc (ADR ) (NYSE:GSK), Showing stories 1 - 10 of about 144. Show all news | Show only top news ...
http://finance.google.com/finance?cid=14456&morenews=10&rating=1  
Alacra Store - GlaxoSmithKline plc Company Snapshot
Major Pharmaceuticals GlaxoSmithKline plc (ADR ) Neutral (#) October ##, #### Q# Solid But Stock's Re ward/Risk Still Looks Neutral Analysts Steve Scala, ...
http://www.alacrastore.com/companysnapshot/1007127  
SIRI Recent stock news - MSN Money
NEWS CORP (NWS), 7 stories... Time Warner Inc. (TWX), 7 stories... Yum! Brands, Inc. (YUM), 6 stories... GlaxoSmithKline plc (ADR ) (GSK), 6 stories. ...
http://news.moneycentral.msn.com/ticker/rcnews.asp?symbol=SIRI  
Salix Pharmaceuticals Ltd (SLXP.O) Stock Quote | Stocks | Reuters.com
Company, 1 Day, 4 Week. GlaxoSmithKline plc (ADR ), -0.23%, -1.48%. Axcan Pharma Inc. (USA), +0.68%, +1.99%. The Procter & Gamble Company, -0.66%, -0.76% ...
http://stocks.us.reuters.com/stocks/overview.asp?symbol=SLXP.O  
Trimeris Inc (TRMS.O) Stock Quote | Stocks | Reuters.com
Price Change:. Company, 1 Day, 4 Week. GlaxoSmithKline plc (ADR ), +1.13%, +0.81%. Pfizer Inc. +1.35%, +4.93%. Schering-Plough Corporation, -0.36%, -1.57% ...
http://stocks.us.reuters.com/.../overview.asp?symbol=TRMS&WTmodLOC=R1-Competitors-2  
Sweetener Case Finally Over (washingtonpost.com)
PepsiCo, Inc. (PEP) • Sanofi-Synthelabo (ADR) (SNY) • Aventis (ADR) (AVE) • Pfizer Inc. (PFE) • GlaxoSmithKline plc (ADR ) (GSK) • Sepracor Inc. (SEPR) ...
http://www.washingtonpost.com/wp-dyn/articles/A22689-2004Jul28.html  
Trimeris Inc (TRMS.O) Stock Quote | Stocks | Reuters.com
Price Change:. Company, 1 Day, 4 Week. GlaxoSmithKline plc (ADR ), -0.06%, +1.08%. Pfizer Inc. +1.25%, -2.10%. Schering-Plough Corporation, +0.04%, +5.04% ...
http://www.investor.reuters.com/.../fullquote&rn=A15AB&symbol=TRMS  
D44603A
GlaxoSmithKline plc ADR GSK 47.00 45.50 58.00 2.09 2.39 22.49 19.67 140.4 ... Market Square in High Point, North Carolina ; The Washington Design Center; ...
http://www.arielcapital.com/.../  
POZEN Inc (POZN.O) Stock Quote | Stocks | Reuters.com
Price Change:. Company, 1 Day, 4 Week. GlaxoSmithKline plc (ADR ), +1.13%, +0.81%. Merck & Co., Inc. +1.24%, -0.09%. AstraZeneca plc (ADR), -1.31%, -5.73% ...
http://today.reuters.com/stocks/Overview.aspx?ticker=POZN&fs=1  
Semiannual Report
GlaxoSmithKline PLC ADR - GB. 4.0%. International Paper Co. 3.8%. Verizon Communications, Inc. 3.7%. Freddie Mac. 3.5%. Bristol-Myers Squibb Co. ...
http://www.gartmorefunds.com/pdf/sar-gvit-vkgcv.pdf  
Ticker List
GLAD Glamis Gold Ltd. GLG Glassmaster Company GLMA Glatfelter GLT GlaxoSmithKline plc (ADR ) GSK Glen Burnie Bancorp GLBZ Glenayre Technologies, ...
http://www.spredgar.com/tickers.htm  
26518 Tax Managed.indd
GlaxoSmithKline plc - ADR (United Kingdom). (Note 7) .......................... ...................................... 3400 ...
http://www.manningnapieradvisors.com/.../Exeter_Funds%5CAnnual_Report%5Ctaxman_20_a.pdf  
GATEX Semi-Annual Report 2006.pmd
GlaxoSmithKline PLC - ADR . 10560. 787822. Johnson & Johnson. 47206. 174100. Lincare Holdings Inc. *. 6588. 38813. Medco Health Solutions, Inc. * ...
http://www.gatewayfund.com/pdfs/GATEXSemi-AnnualReport2006.pdf  
GATEX Annual Report 2005.pmd
GlaxoSmithKline PLC - ADR . 5449. 54950. Guidant Corporation. 3558. 6500. Hillenbrand Industries, Inc. 321. 737722. Johnson & Johnson ...
http://www.gatewayfund.com/pdfs/GATEXAnnualReport2005.pdf  
GlaxoSmithKline - Do more, feel better, live longer
This site serves as the homepage of GSK's corporate web site.
http://www.gsk.com/  
printmgr file
GlaxoSmithKline PLC ADR —GB. 4.3%. Freddie Mac. 4.0%. AT&T, Inc. 3.6%. International Paper Co. 3.6%. Citigroup, Inc. 3.4%. Verizon Communications, Inc. ...
http://www.nwdfunds.com/pdf/ar-gvit-vkgcv.pdf  
Northern Funds - Equity - Annual Report
GlaxoSmithKline PLC ADR . 110000. 5754. King Pharmaceuticals, Inc. * ... First Bancorp of North Carolina . 4590. 103. First Charter Corp. ...
http://www.northernfunds.com/resources/financial/docs/nf_annual_equity.pdf  
GLENMEDE THE GLENMEDE FUND, INC. THE GLENMEDE PORTFOLIOS SEMI ...
5300000, University of North Carolina at Chapel Hill, Hospital Revenue, ... 7139, GlaxoSmithKline PLC ADR 2, 406066. 44280, Pfizer, Inc. 1121612 ...
http://content.members.fidelity.com/.../?format=html&part=CONTENT&consent=N  
GLENMEDE THE GLENMEDE FUND, INC. THE GLENMEDE PORTFOLIOS ANNUAL ...
13130000, University of North Carolina at Chapel Hill, Hospital Revenue, ... 4900, GlaxoSmithKline PLC ADR , 254751. 20350, Pfizer, Inc. 442409 ...
http://content.members.fidelity.com/.../?format=html&part=CONTENT&consent=N  
JPMorgan TaxAware
GlaxoSmithKline plc ADR (United Kingdom) ... North Carolina Municipal Power Agency No. 1,. Catawba Electric Rev., MBIA, 6.00%,. 01/01/11. 246. Ohio — 16.3% ...
http://www.jpmorganfunds.com/pdfs/current/SAN-TA.PDF  
"GLAXOSMITHKLINE", NORTHCAROLINA
GlaxoSmithKline ( North Carolina )
GlaxoSmithKline ( North Carolina ). Formerly Glaxo Wellcome 5 Moore Drive, P.O. Box 13398 Research Triangle Park, North Carolina 27709 U.S.A. ...
http://www.biospace.com/company_profile.aspx?CompanyId=1395  
Biospace.com
GlaxoSmithKline ( North Carolina ) News from The BioSpace Beat ... GlaxoSmithKline Consumer Healthcare Launches Suit To Stop Misleading Marketing Of Unproven ...
http://www.biospace.com/news_company.aspx?companyID=1395  
GlaxoSmithKline USA: Homepage
GlaxoSmithKline USA: Homepage. ... GlaxoSmithKline announces new patient assistance programs for low-income Medicare Part D patients December 07,2006 ...
http://us.gsk.com/  
GlaxoSmithKline USA: NC GSK Foundation
The Community section describes GSK's community and philanthropic initiatives.
http://us.gsk.com/community/ncfound.htm  
In the community - GlaxoSmithKline
See GSK.com for information on GlaxoSmithKline's contributions to health and ... The Foundation supports activities in North Carolina that help meet the ...
http://www.gsk.com/community/index.htm  
NORTH CAROLINA GLAXOSMITHKLINE FOUNDATION AWARDS GRANTS TO PROMOTE ...
RESEARCH TRIANGLE PARK, NC – The North Carolina GlaxoSmithKline Foundation today. announced new grants for the 2004 fiscal year for programs that promote ...
http://www.gsk.com/press_archive/press2005/gcp_03142005.pdf  
CAT.INIST.FR
(5) Department of Research Bioanalysis and Drug Metabolism, GlaxoSmithKline , Research Triangle Park, North Carolina 27709, ETATS-UNIS ...
http://cat.inist.fr/?aModele=afficheN&cpsidt=16712659  
5th Gene Delivey & Cellular Protein Expression Conference Speakers
Patrick Condreay - GlaxoSmithKline , North Carolina , USA; François-Loïc Cosset - Vectorologie Rétrovirale et Thérapie Génique, INSERM, Lyon, France ...
http://www.boku.ac.at/iam/5gdcpe/speaker.html  
Alpha-A-crystallin is a target gene of the Farnesoid X-activated ...
GlaxoSmithKline Research and Development, Research Triangle. Park, North Carolina 27709. Running Title: FXR and alpha-A-crystallin ...
http://www.jbc.org/cgi/reprint/M503182200v1.pdf  
N.C. Prevention Partners, GlaxoSmithKline to announce ...
N.C. Prevention Partners, GlaxoSmithKline to announce collaboration to combat ... addressing the epidemic of overweight children in North Carolina . ...
http://www.unc.edu/news/media/2004/ncprevent032604.html  
UNC News release -- GlaxoSmithKline funds $1.65 million effort for ...
CHAPEL HILL — The North Carolina GlaxoSmithKline Foundation has awarded $1.65 million to the University of North Carolina at Chapel Hill and Duke University ...
http://www.unc.edu/news/archives/feb06/gskbluegrant020706.htm  
Local Section Officers
North Carolina State University michael_goshe@ncsu.edu. C. A. Goss GlaxoSmithKline Inc. 3030 Cornwallis Rd. Research Triangle Park NC 27709 ...
http://membership.acs.org/n/ncarolina/directory.html  
ISPOR Newsletter Volume 7 Number 3
... USA; and Zeba Khan PhD, Senior Health Outcomes Scientist, GlaxoSmithKline , North Carolina , USA, were heralded for their distinguished service to ISPOR, ...
http://www.ispor.org/news/articles/0703/meeting_.html  
Table of Contents
GlaxoSmithKline , North Carolina . Interfaced with NCDENR and EPA Region IV personnel during the development of the Comprehensive Performance Test (CPT) Plan, ...
http://www.cs2inc.com/downloads/qualstatement.doc  
GlaxoSmithKline - Wikipedia, the free encyclopedia
Current members of the board of directors of GlaxoSmithKline are: ... Also, the production center was moved from New York to North Carolina in 1970 and the ...
http://en.wikipedia.org/wiki/GlaxoSmithKline  
GlaxoSmithKline 2005-06 sponsorship release.indd
North Carolina ,” said Robert Nash, Manager of Environmental Health and Safety at GlaxoSmithKline . NC GreenPower’s success revolves around corporate sponsors ...
http://www.ncgp.org/.../GlaxoSmithKline%202005-06%20sp...  
Minority Job Search Engine Offers Diversity Jobs In The Workplace
Administrative Assistant, GlaxoSmithKline , NC-Research Trianlge Park ... Open Access LCMS Technician, GlaxoSmithKline , NC-Research Triangle Park ...
http://www.diversityworking.com/career/stateCareers.php/North_Carolina_jobs/  
Layout 1 (Page 1)
GlaxoSmithKline Pharma. , and the. GlaxoSmithKline North Carolina Foundation. have established the GlaxoSmithKline . Endowed Chair in Cancer Research at the ...
http://alumni.musc.edu/development/newsletter/2004_10.pdf  
Glaxosmithkline Inc | Research Triangle Pa, North Carolina (NC ...
Glaxosmithkline Inc in Research Triangle Pa, NC | Mfg Pharmaceutical Preps Coml Physical Research company | Purchase company reports highlighting ...
http://www.manta.com/coms2/dnbcompany_c466hb  
Connecting in North Carolina : Weblog
Connecting in North Carolina The bus tour that takes NCSU's teaching, ... GlaxoSmithKline was - impressive! We had a very well-coordinated tour of their ...
http://blogs.lib.ncsu.edu/page/cinc?catname=%2FGlaxoSmithKline